Peter Marks, director, Center for Biologics Evaluation and Research, FDA, presented the keynote...
Author - David Miller
How to Enhance DEI in Clinical Trials
Integrating DEI strategies into clinical trials is both crucial for advancing biomedical knowledge...
Advantages & Disadvantages of Using Compounded Medications
Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy...
EquipNet, Agilent Enter Reseller Agreement for Certified...
The agreement follows Agilent’s acquisition of Canada-based CDMO BIOVECTRA in July 2024.
The Impact of Artificial Intelligence on the Creation of...
Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director...
Merck Agrees to Terms to Acquire Modifi Biosciences
Under terms of the deal, Merck will provide an upfront payment of $30 million, with potential...
Retrofitting Facilities for Cell and Gene Therapy Production
In this episode of the Ask the Expert video series, Peter Walters, Fellow of Advanced Therapies at...
FDA Approves Pfizer’s RSV Vaccine for Adults 18-59
Abrysvo had previously been approved for adults 60-years and older.
Behind the Headlines: GLP-1 Shortage, Nobel Prize, RNA Editing...
Laks Pernenkil, Brian Feth, and Alex Philippidis go behind the headlines to discuss the impact of...
Identifying Illicit Actors vs Compound Pharmacies
Scott Brunner, CEO of the Alliance for Pharmacy Compounding, explains how to identify a compound...